Entero Healthcare Solutions Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Entero Healthcare Solutions Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Entero Healthcare Solutions shares trading at Rs.1,194 against a market capitalisation of Rs.5,285 Cr and a price-to-earnings multiple of 36.2. As a healthcare services name on the NSE and BSE, Entero Healthcare Solutions enters the Entero Healthcare Solutions Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

This Entero Healthcare Solutions Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.1,410 Cr revenue and Rs.30 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.

Get Free Investment Predictions and Entero Healthcare Solutions Research at Univest

About Entero Healthcare Solutions

Entero Healthcare Solutions (NSE: ENTERO) operates in the healthcare services space and is tracked on Univest under its NSE and BSE listings. Ahead of the Entero Healthcare Solutions Q1 Results FY27 print, the company’s most recent reported quarter (Q4 FY26) shows revenue of Rs.1,914 Cr and net profit of Rs.45 Cr, forming the base against which the Entero Healthcare Solutions Q1 Results FY27 estimates in this article are built. This Entero Healthcare Solutions Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.

Entero Healthcare Solutions Q1 FY27 Estimates

Metric	Q1 FY27E (Range)	Q1 FY26 Actual	YoY Growth
Revenue (Rs. Cr)	1,864-2,144	1,410	+42.2%
Net Profit / PAT (Rs. Cr)	38-49	30	+43.6%
Results Date	July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate)	Rs.1,432-1,587

Univest, a SEBI-Registered Investment Advisor, Tracks Entero Healthcare Solutions Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Occupancy and ARPOB Trends

Occupancy and ARPOB improvement across hospital and diagnostic networks is one of the primary variables that analysts are tracking ahead of Entero Healthcare Solutions’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Entero Healthcare Solutions share price target or faces renewed pressure.

2. Capacity Addition

Capacity addition through new beds or centres supporting medium-term growth is one of the primary variables that analysts are tracking ahead of Entero Healthcare Solutions’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Entero Healthcare Solutions share price target or faces renewed pressure.

3. Case Mix Improvement

Case mix improvement toward higher-margin specialties aiding profitability is one of the primary variables that analysts are tracking ahead of Entero Healthcare Solutions’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Entero Healthcare Solutions share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Entero Healthcare Solutions’s live price and Q1 FY27 result updates.

Key Risks to the Entero Healthcare Solutions Q1 Results FY27 Outlook

• Slower occupancy ramp-up in newly added capacity affecting near-term margins.
• Regulatory changes to pricing or insurance reimbursement norms.
• Talent cost inflation for specialist doctors and clinical staff.

Q4 FY26 Performance Context for the Entero Healthcare Solutions Q1 Results FY27 Print

Entero Healthcare Solutions closed Q4 FY26 with revenue of Rs.1,914 Cr and net profit of Rs.45 Cr, a year-on-year revenue change of +42.2% and PAT change of +43.6% versus Q4 FY25. This base underpins the Entero Healthcare Solutions Q1 Results FY27 projection used in this preview and should be read alongside the company’s own Entero Healthcare Solutions Q1 Results FY27 commentary once reported.

Technical Analysis Ahead of Entero Healthcare Solutions Q1 Results FY27

Entero Healthcare Solutions shares last traded at Rs.1,194. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Entero Healthcare Solutions Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Entero Healthcare Solutions Q1 Results FY27 trailing-growth framework points to a range of Rs.1,250-1,346 for Entero Healthcare Solutions, contingent on the Entero Healthcare Solutions Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Entero Healthcare Solutions Q1 Results FY27 view for Entero Healthcare Solutions works out to Rs.1,432-1,587, built on the same trailing revenue growth trend and current valuation multiple. Tracking with a constructive bias is how Univest research categorises the stock heading into Entero Healthcare Solutions Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Entero Healthcare Solutions Q1 Results FY27 analysis would put Entero Healthcare Solutions in a Rs.1,635-1,850 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.

What to Watch in the Entero Healthcare Solutions Q1 Results FY27 Print

• Revenue and PAT versus the Entero Healthcare Solutions Q1 Results FY27 estimate range in this preview.
• Management commentary on FY27 growth guidance and margin trajectory relevant to the Entero Healthcare Solutions Q1 Results FY27 narrative.
• Occupancy and ARPOB improvement across hospital and diagnostic networks
• Slower occupancy ramp-up in newly added capacity affecting near-term margins

Conclusion on Entero Healthcare Solutions Q1 Results FY27

Entero Healthcare Solutions enters the Q1 FY27 results season trading at Rs.1,194, with the 12-month Uniresearch target range of Rs.1,432-1,587 reflecting a tracking with a constructive bias stance. Investors tracking the Entero Healthcare Solutions Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

FAQs on Entero Healthcare Solutions Q1 Results FY27

When are Entero Healthcare Solutions Q1 FY27 results expected?

Ans. Entero Healthcare Solutions’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Entero Healthcare Solutions Q1 FY27 revenue estimate?

Ans. The Uniresearch trailing-growth estimate for Entero Healthcare Solutions’s Q1 FY27 revenue is Rs.1,864-2,144 Cr, based on the Q1 FY26 base of Rs.1,410 Cr.

What is the Entero Healthcare Solutions share price target?

Ans. The 12-month Uniresearch estimate for Entero Healthcare Solutions share price target is Rs.1,432-1,587, based on trailing growth and current valuation multiples.

Is Entero Healthcare Solutions a good buy before Q1 FY27 results?

Ans. Entero Healthcare Solutions is tracking with a constructive bias heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Entero Healthcare Solutions’s Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and occupancy and ARPOB improvement across hospital and diagnostic networks.

Where can I track Entero Healthcare Solutions share price live?

Ans. Entero Healthcare Solutions share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.